Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

NCT00326118 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

433

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilus Influenzae Type b
Neisseria Meningitidis

Interventions

BIOLOGICAL: Haemophilus influenzae type b and meningococcal serogroup C (vaccine)
BIOLOGICAL: Priorix™
BIOLOGICAL: Hiberix™
BIOLOGICAL: Meningitec™

Sponsor

GlaxoSmithKline